Global Health Rajdeep Panwar Resigns from GHL Pharma Subsidiary

Global Health Limited announced the resignation of Rajdeep Panwar from his position as Director and Manager of GHL Pharma & Diagnostic Private Limited, a wholly-owned subsidiary. The resignation, accepted by the Board of Directors, will be effective from December 28, 2025. Panwar is also stepping down as a Senior Management Personnel of the Company to pursue opportunities outside Medanta.

Senior Management Change

Rajdeep Panwar has resigned from his position as Director and Manager of GHL Pharma & Diagnostic Private Limited, a wholly-owned subsidiary of Global Health Limited. He was also designated as one of the Senior Management Personnel of the Company.

Effective Date of Resignation

The resignation will be effective from December 28, 2025. The Board of Directors has accepted Mr. Panwar’s resignation letter.

Reason for Departure

Mr. Panwar is resigning to pursue opportunities outside of Medanta, according to the company’s statement.

Source: BSE

InvestyWise News
InvestyWise News
Covers market-moving news with speed and precision, delivering sharp insights to help readers stay ahead in the fast-paced world of stocks.

Latest articles

Related articles

Leave a reply

Please enter your comment!
Please enter your name here
Captcha verification failed!
CAPTCHA user score failed. Please contact us!